N/A
N=220
Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison
Heart Failure
Bottom Line
View on ClinicalTrials.gov: NCT01002456 ↗Enrolled (actual)
220
Serious AEs
0.0%
Results posted
Oct 2014
Primary outcome: Primary: Rate of Adherence to Guideline Prescription — 4; 6 patients
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Level 1: (provide site-specifi information) (Other); Level 2 (Provide site- and patient-specific information) (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rate of Adherence to Guideline Prescription |
4; 6 | — |
| SECONDARY Progress Toward Adherence to Guideline Prescription |
10; 22 | — |
Summary
The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.
Eligibility Criteria
Inclusion Criteria
- VA sites
- Males and females
Exclusion Criteria
none
Data sourced from ClinicalTrials.gov (NCT01002456). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.